Max Robotics — Global Service Robot Directory + US Certification

About

Jonathan Garnier is a leading figure in the advancement of minimally invasive pancreatic surgery, with a focused expertise in left pancreatectomy and complex vascular resections. His research is pivotal in understanding and mitigating the risks of conversion during minimally invasive left pancreatectomy (MILP). In his highly cited 2025 work, Garnier identified key risk factors for conversion and developed a predictive Conversion Risk Score (CRS), demonstrating a direct link between conversion and severe postoperative complications. This work, with 4 citations, provides surgeons with a critical tool for preoperative planning and patient counseling. Beyond risk stratification, Garnier is a pioneer in technical innovation, as evidenced by his educational video on robotic distal pancreatectomy with celiac axis resection and SMA divestment. This step-by-step guide, cited 2 times, offers a reproducible roadmap for tackling the most challenging cases. Through his dual focus on predictive analytics and advanced surgical technique, Garnier is shaping safer, more effective outcomes in the field of pancreatic surgery.